• SENSEX 81,534.81
    -261.34 (--0.32%)
  • BANKNIFTY 55,944.90
    417.55 (+0.75%)
  • Vishal Mega Mart
    127.85 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,155.00 2,301.55(%)
  • Tata Motors
    673.10 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bacil Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3688.0
  • ISIN : INE711D01018
37.68 -2 (-4.56%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    37.51

  • Today’s High

    39.45

  • Open

    37.51

  • Perv Close

    39.48

  • 52W Low

    14.85

  • 52W High

    62.56

Key Indicators

  • P/E(TTM)

    54.61

  • Mar.Cap (₹Cr.)

    22.19

  • Div & Yield %

    0.00

  • Book Value(₹)

    29.46

  • Debt-Equity Ratio

    -4.56

  • AGM Date

    16-Jun-2025

  • EPS

    0.69

  • P/E Ratio

    54.61

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    22.19

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.89

  • BV (₹)

    29.50

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    0.40

  • NP Var(%)

    353.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    22.19

  • 52 Week High

    62.56

  • 52 Week Low

    14.85

  • Price BSE

    38.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    22.19

  • P/C Ratio

    55.30

  • P/E Ratio

    55.40

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.13 0.11 0.06 0.07 0.14 0.09
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.13 0.11 0.06 0.07 0.14 0.09
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.01
Employee Cost 0.10 0.09 0.06 0.05 0.09 0.08
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.01
Selling and Administration Expenses 0.08 0.08 0.09 0.08 0.08 0.16
Miscellaneous Expenses 0.00 0.05 3.76 0.17 0.26 0.18
Employee Benefit Expenses 0.10 0.09 0.06 0.05 0.09 0.08
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.19 0.21 3.91 0.30 0.44 0.43
Operating Profit -0.06 -0.10 -3.86 -0.23 -0.30 -0.33
Interest 0.00 0.00 0.00 0.00 0.01 0.00
Gross Profit -0.06 -0.10 -3.86 -0.23 -0.31 -0.33
Depreciation 0.00 0.00 0.00 0.00 0.01 0.01
Profit Before Tax -0.06 -0.10 -3.86 -0.23 -0.32 -0.34
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Extraordinary Items 0.10 0.05 -3.76 -0.14 -0.26 -0.16
Adjusted Net Profit -0.16 -0.15 -0.10 -0.10 -0.06 -0.18
Adjustment below Net Profit 0.17 -0.02 3.69 0.24 -0.21 0.02
P & L Balance brought forward -5.43 -5.30 -5.14 -5.14 -4.62 -4.29
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.31 -5.43 -5.30 -5.14 -5.14 -4.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.09 -0.16 -5.91 -0.37 -0.48 0.00
Earnings Per Share(Adj)-Unit Curr -0.09 -0.16 -5.91 -0.37 -0.48 -
Book Value 1.86 1.68 1.88 2.13 2.12 2.93
Book Value(Adj)-Unit Curr 1.86 1.68 1.88 2.13 2.12 -

Shareholding Pattern

  • Promoter Group

    0.20%

  • Public Share Holding

    99.80%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 11,000 0.19 0 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 500 0.01 0 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,500 0.20 0 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,084,144 18.41 1,035,544 24
Clearing Members 152,000 2.58 152,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 86,120 1.46 12,520 107
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 93,090 1.58 93,090 22
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,597,025 27.11 1,483,025 24
Individuals holding nominal share capital up to Rs. 1 lakh 2,865,921 48.66 947,321 7,456
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 200 0.00 200 1
Others 0 0.00 0 0
Sub Total 5,878,500 99.80 3,723,700 7,635
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,890,000 100.00 3,723,700 7,638

Company Background

Bacil Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Bacil Pharma Ltd
  • BSE Code : 3688.0
  • ISIN : INE711D01018

  • Incorporation Year

    1987

  • Registered Office

    G2 & G3 Samarpan Complex
    chakala Andheri East, Mumbai,
    Maharashtra-400099

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Bhavana Tak

  • Auditor

    Laxmikant Kabra & Co LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

Bacil Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bacil Pharma 37.68 0.13 0.00 54.61 0.00
Abbott India 31,658.15 6,097.18 5,848.91 47.56 44.71
Astrazeneca Phar 10,204.20 1,330.33 1,295.53 220.39 33.26
P & G Health Ltd 5,907.60 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,366.50 3,866.05 3,723.49 62.06 58.72
Cipla 1,526.90 17,645.00 16,574.34 23.91 20.10
Amrutanjan Healt 700.10 437.58 421.23 39.82 20.84
Guj. Themis Bio. 349.55 174.19 169.82 78.02 44.82
Fermenta Biotec. 341.00 315.24 307.09 14.85 4.10
Bliss GVS Pharma 147.30 638.96 605.46 22.49 11.19
Ambalal Sarabhai 36.91 11.70 3.81 34.18 1.92